Milestone Pharmaceuticals (MIST) Institutional Ownership $1.84 -0.01 (-0.54%) (As of 11/22/2024 ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Milestone Pharmaceuticals (NASDAQ:MIST)CurrentInstitutional OwnershipPercentage86.18%Number ofInstitutional Buyers(last 12 months)5TotalInstitutional Inflows(last 12 months)$733.53KNumber ofInstitutional Sellers(last 12 months)3TotalInstitutional Outflows(last 12 months)$809.97K Get MIST Insider Trade Alerts Want to know when executives and insiders are buying or selling Milestone Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data MIST Institutional Buying and Selling by Quarter Ad Weiss Ratings“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.Learn these 4 simple steps and protect your savings before it’s too late. Milestone Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/14/2024 Stonepine Capital Management LLC999,790$1.52M1.0%-19.3%1.877% 11/5/2024 BML Capital Management LLC1,136,091$1.73M1.0%+3.0%2.133% 11/1/2024 Atria Investments Inc40,421$61K0.0%+44.4%0.076% 10/10/2024 Valeo Financial Advisors LLC20,000$30K0.0%+100.0%0.038% 8/21/2024 Stonepine Capital Management LLC1,239,199$1.64M1.5%-15.3%2.327% 8/15/2024 Lion Point Capital LP2,340,207$3.09M5.6%+1.7%4.394% Get the Latest News and Ratings for MIST and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Milestone Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 8/15/2024 Millennium Management LLC2,749,930$3.66M0.0%-3.7%5.163% 5/1/2024 BNP Paribas Financial Markets16,900$30K0.0%+177.0%0.032% 4/26/2024 Clear Creek Financial Management LLC25,000$45K0.0%-21.3%0.047% 4/23/2024 BML Capital Management LLC606,145$1.09M0.7%+37.0%1.140% 1/30/2024 BML Capital Management LLC442,352$739K0.6%+62.3%1.321% 9/21/2023 Barclays PLC800,776$2.28M0.0%-5.4%2.399% 8/21/2023 Affinity Asset Advisors LLC300,068$855K0.3%+50.5%0.899% 8/11/2023 Beta Wealth Group Inc.14,127$40K0.0%N/A0.042% 8/3/2023 Barclays PLC800,776$2.28M0.0%-5.4%2.400% 7/27/2023 Virtu Financial LLC11,743$33K0.0%N/A0.035% 7/24/2023 BML Capital Management LLC272,500$777K0.7%+23.9%0.817% 7/17/2023 Clear Creek Financial Management LLC31,929$91K0.0%-11.1%0.096% 7/14/2023 Valeo Financial Advisors LLC118,699$338K0.0%+4.4%0.356% 5/16/2023 Alta Fundamental Advisers LLC897,961$3.54M1.5%+58.8%2.698% 5/15/2023 Affinity Asset Advisors LLC199,382$786K0.3%+99.4%0.599% 5/15/2023 RTW Investments LP3,256,102$12.83M0.3%-24.5%9.782% 5/4/2023 Barclays PLC846,828$3.34M0.0%+32.0%2.544% 4/20/2023 Clear Creek Financial Management LLC35,929$142K0.0%N/A0.108% 4/14/2023 BML Capital Management LLC220,000$867K0.7%+22.2%0.661% 2/15/2023 Braidwell LP1,164,849$4.61M0.2%N/A3.397% 2/14/2023 VR Adviser LLC2,208,812$8.75M1.4%-8.9%6.442% 2/14/2023 Pura Vida Investments LLC371,788$1.47M0.1%-37.7%1.084% 2/13/2023 BML Capital Management LLC180,000$713K0.7%N/A0.525% 2/13/2023 Beta Wealth Group Inc.14,127$56K0.0%N/A0.041% 2/9/2023 Valeo Financial Advisors LLC113,699$450K0.0%+50.6%0.332% 2/1/2023 Bank of Montreal Can152,636$611K0.0%+217.3%0.445% 11/15/2022 Pura Vida Investments LLC596,531$5.48M0.3%-39.6%1.740% 11/15/2022 Boxer Capital LLC698,861$6.42M0.4%-68.8%2.038% 11/14/2022 LMR Partners LLP38,495$354K0.0%+228.1%0.128% 11/14/2022 VR Adviser LLC2,425,737$22.29M3.3%N/A8.083% 11/3/2022 Barclays PLC540,582$4.97M0.0%+155.3%1.801% 10/31/2022 Valeo Financial Advisors LLC75,500$694K0.0%N/A0.252% 10/13/2022 National Bank of Canada FI2,880$26K0.0%-80.6%0.010% 8/15/2022 Acuta Capital Partners LLC457,200$2.81M1.6%+20.3%1.528% Missed Nvidia? Watch this ASAP (Ad)This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrough so advanced, it’s going to make ChatGPT look like VHS. But what’s even more unbelievable? I believe it’ll make Nvidia’s meteoric rise look like a backyard bottle rocket.Click here and I’ll tell you everything you need to know.2/14/2022 Boxer Capital LLC2,238,861$14.67M0.6%-13.0%7.501% 2/14/2022 Eversept Partners LP147,165$964K0.1%+29.6%0.493% 2/10/2022 Bleichroeder LP250,000$1.64M0.3%N/A0.838% 2/10/2022 Acadian Asset Management LLC12,381$79K0.0%+63.0%0.041% 1/24/2022 National Bank of Canada FI14,742$96K0.0%N/A0.049% 11/16/2021 Millennium Management LLC695,241$3.97M0.0%-3.3%2.329% 11/15/2021 Pura Vida Investments LLC850,312$4.86M0.1%+21.0%2.849% 11/15/2021 Eversept Partners LP113,597$649K0.0%N/A0.381% 11/9/2021 Barclays PLC200,688$1.15M0.0%-1.6%0.672% 8/18/2021 Ikarian Capital LLC1,980,400$10.89M0.9%+7.8%6.635% 8/17/2021 Boothbay Fund Management LLC224,758$1.24M0.0%+7.9%0.753% 8/16/2021 Morgan Stanley885,199$4.87M0.0%+4.0%2.966% 8/13/2021 Renaissance Technologies LLC107,554$592K0.0%-50.3%0.360% 8/12/2021 Dimensional Fund Advisors LP47,200$260K0.0%+23.2%0.158% 8/11/2021Susquehanna Fundamental Investments LLC51,502$283K0.0%-15.1%0.173% 5/18/2021 Millennium Management LLC717,797$4.16M0.0%-2.4%2.405% 5/18/2021 RA Capital Management L.P.2,246,503$13.01M0.2%-3.5%7.527% 5/18/2021 Morgan Stanley851,042$4.93M0.0%-13.0%2.851% 5/18/2021 Orbimed Advisors LLC2,583,821$14.96M0.1%+3.6%8.657% 5/18/2021 Boxer Capital LLC2,572,194$14.89M0.5%+3.8%8.618% 5/17/2021 Price T Rowe Associates Inc. MD267,997$1.55M0.0%-28.5%0.898% 5/17/2021 Goldman Sachs Group Inc.12,004$70K0.0%-46.0%0.040% 5/14/2021 Dimensional Fund Advisors LP38,316$222K0.0%+71.4%0.128% 5/14/2021 TD Asset Management Inc.18,704$108K0.0%-18.9%0.063% 5/13/2021 Barclays PLC156,876$909K0.0%+320.4%0.526% 5/13/2021 Renaissance Technologies LLC216,400$1.25M0.0%+32.0%0.725% 5/12/2021 Geode Capital Management LLC20,859$120K0.0%+10.1%0.070% 5/12/2021 Pura Vida Investments LLC467,640$2.71M0.1%+3.9%1.567% 3/26/2021 Susquehanna International Group LLP10,144$68K0.0%N/A0.034% 3/8/2021 Dimensional Fund Advisors LP22,355$150K0.0%N/A0.075% 2/25/2021 Dimensional Fund Advisors LP22,355$150K0.0%N/A0.075% 2/16/2021 Orbimed Advisors LLC2,493,109$16.70M0.1%+546.2%8.360% 2/16/2021 Squarepoint Ops LLC23,633$158K0.0%N/A0.079% 2/16/2021 Morgan Stanley977,741$6.55M0.0%+34.4%3.278% 2/16/2021 Pura Vida Investments LLC450,000$3.02M0.1%+350.0%1.509% 2/16/2021 Price T Rowe Associates Inc. MD374,957$2.51M0.0%-35.0%1.257% 2/12/2021 Ikarian Capital LLC1,836,545$12.31M0.5%+5.3%6.158% 2/10/2021 Renaissance Technologies LLC164,000$1.10M0.0%+986.1%0.550% 11/17/2020 Boxer Capital LLC1,777,194$13.01M0.4%+61.2%7.192% 11/16/2020 Boothbay Fund Management LLC198,708$1.46M0.1%+315.7%0.804% 11/13/2020 Morgan Stanley727,239$5.32M0.0%+21.5%2.943% 11/10/2020 State Street Corp17,562$129K0.0%N/A0.071% 11/5/2020 California Public Employees Retirement System51,200$375K0.0%+61.0%0.207% (Data available from 1/1/2016 forward) MIST Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of MIST shares? During the previous two years, 18 institutional investors and hedge funds held shares of Milestone Pharmaceuticals. The most heavily invested institutionals were RTW Investments LP ($12.83M), VR Adviser LLC ($8.75M), Braidwell LP ($4.61M), Millennium Management LLC ($3.66M), Alta Fundamental Advisers LLC ($3.54M), Lion Point Capital LP ($3.09M), and Barclays PLC ($2.28M).Learn more on MIST's institutional investors. What percentage of Milestone Pharmaceuticals stock is owned by institutional investors? 86.18% of Milestone Pharmaceuticals stock is owned by institutional investors. Learn more on MIST's institutional investor holdings. Which institutional investors have been buying Milestone Pharmaceuticals stock? Of the 13 institutional investors that purchased Milestone Pharmaceuticals stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Braidwell LP ($1.16M), BML Capital Management LLC ($639.34K), Alta Fundamental Advisers LLC ($332.50K), Barclays PLC ($205.48K), Affinity Asset Advisors LLC ($200.07K), Bank of Montreal Can ($104.54K), and Valeo Financial Advisors LLC ($53.20K). How much institutional buying is happening at Milestone Pharmaceuticals? Institutional investors have bought a total of 2,839,124 shares in the last 24 months. This purchase volume represents approximately $10.02M in transactions. Which Milestone Pharmaceuticals major shareholders have been selling company stock? The following institutional investors have sold Milestone Pharmaceuticals stock in the last 24 months: RTW Investments LP ($1.06M), Stonepine Capital Management LLC ($462.51K), Pura Vida Investments LLC ($224.74K), VR Adviser LLC ($216.93K), Millennium Management LLC ($105.68K), Barclays PLC ($92.10K), and Clear Creek Financial Management LLC ($10.75K). How much institutional selling is happening at Milestone Pharmaceuticals? Institutional investors have sold a total of 2,171,710 shares in the last 24 months. This volume of shares sold represents approximately $7.01M in transactions. Related Companies VERU Major Shareholders SLGL Major Shareholders LRMR Major Shareholders TNGX Major Shareholders VERV Major Shareholders TKNO Major Shareholders CTNM Major Shareholders FDMT Major Shareholders ALEC Major Shareholders DNA Major Shareholders This page (NASDAQ:MIST) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Milestone Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Milestone Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
